T63.062S Toxic effect of venom of other North and South American snake, intentional self-harm, sequela

Name of the Condition

• Toxic effect of venom of other North and South American snake, intentional self-harm, sequela
• ICD-10-CM Code: T63.062S

Summary

This condition describes the residual adverse health effects resulting from intentional exposure to the venom of non-rattlesnake, non-cobra, and non-sea snake species native to North and South America. The code is used when the toxic effects of such venom are the primary focus of the encounter, the exposure was deliberate, and the condition is in the sequela phase (residual effects after the acute phase has resolved).

Causes

The condition is caused by the injection of venom from a North or South American snake into the body, usually via a bite, with the exposure being intentional. Venom contains various toxins that can affect multiple organ systems, leading to systemic or localized reactions during the acute phase, with residual effects persisting in the sequela phase.

Risk Factors

• Deliberate exposure to venomous snakes.
• Activities involving intentional contact with snakes (e.g., handling or provoking).
• Lack of protective measures during intentional interactions.

Symptoms

• Persistent localized pain, swelling, or discoloration at the bite site.
• Chronic systemic effects such as fatigue, muscle weakness, or neurological deficits.
• Long-term hemotoxic effects (e.g., coagulation abnormalities or tissue damage).
• Psychological sequelae related to the intentional exposure.

Diagnosis

Diagnosis is based on clinical evaluation, including patient history of intentional snake exposure, physical examination of residual effects, and correlation with prior acute-phase documentation. Imaging or laboratory tests may be used to assess ongoing tissue or organ damage.

Treatment Options

Treatment focuses on managing residual symptoms and preventing further complications. This may include pain management, physical therapy for functional deficits, psychological support, and monitoring for delayed organ system effects. Specific interventions depend on the nature and severity of the sequela.

Prognosis and Follow-Up

Prognosis varies based on the extent of initial venom exposure and the body systems affected. Regular follow-up is recommended to monitor for late complications, adjust treatment plans, and address any persistent symptoms or functional limitations.

Complications

• Chronic pain or tissue damage at the bite site.
• Persistent neurological deficits (e.g., weakness or sensory changes).
• Long-term coagulation disorders or organ dysfunction.
• Psychological impact, including anxiety or depression related to the event.

Lifestyle & Prevention

• Avoid intentional contact with venomous snakes to prevent recurrence.
• Follow-up with healthcare providers to manage residual symptoms.
• Engage in rehabilitation or therapy as recommended to improve functional outcomes.
• Seek mental health support if psychological effects are present.

When to Seek Professional Help

Seek medical attention if new or worsening symptoms develop, such as increased pain, swelling, neurological changes, or signs of infection at the bite site. Prompt evaluation is important to address complications or adjust treatment.

Tips for Medical Coders

Use this code for sequela (residual effects) of intentional self-harm from venom of other North and South American snakes. Document the residual effects, intentional nature of exposure, and correlation with the acute phase. Ensure the sequela is clearly linked to the prior toxic effect and that the code is not used for acute-phase encounters.